Perivascular spaces--MRI marker of inflammatory activity in the brain?

The Virchow-Robin spaces (VRS), perivascular compartments surrounding small blood vessels as they penetrate the brain parenchyma, are increasingly recognized for their role in leucocyte trafficking as well as for their potential to modulate immune responses. In the present study, we investigated VRS numbers and volumes in different brain regions in 45 multiple sclerosis patients and 30 healthy controls of similar age and gender distribution, applying three different MRI sequence modalities (T(2)-weighted, T(1)-weighted and FLAIR). VRS were detected in comparable numbers in both multiple sclerosis patients and healthy individuals, indicating that perivascular compartments present on MRI are not a unique feature of multiple sclerosis. However, multiple sclerosis patients had significantly larger VRS volumes than healthy controls (P = 0.004). This finding was not explained by a significantly lower brain parenchymal fraction (BPF), resulting from a higher degree of atrophy, in the patient cohort. In a multiple linear regression analysis, age had a significant influence on VRS volumes in the control group but not in multiple sclerosis patients (P = 0.023 and P = 0.263, respectively). A subsequent prospective longitudinal substudy with monthly follow-up MRI over a period of up to 12 months in 18 patients revealed a significant increase in VRS volumes and counts accompanying the occurrence of contrast-enhancing lesions (CEL). At time points when blood-brain barrier (BBB) breakdown was indicated by the appearance of CEL, total VRS volumes and counts were significantly higher compared with preceding time points without CEL (P = 0.011 and P = 0.041, respectively), whereas a decrease thereafter was not statistically significant. Thus, our data points to an association of VRS with CEL as a sign for inflammation rather than with factors such as age, observed in healthy controls, and therefore suggests a role of VRS in inflammatory processes of the brain.

[1]  J. Winn,et al.  Brain , 1878, The Lancet.

[2]  W. Hickey,et al.  Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.

[3]  L. Heier,et al.  Large Virchow-Robin spaces: MR-clinical correlation. , 1989, AJNR. American journal of neuroradiology.

[4]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[5]  W. Hickey.  Migration of Hematogenous Cells Through the Blood‐Brain Barrier and the Initiation of CNS Inflammation , 1991, Brain pathology.

[6]  N. Van Rooijen,et al.  Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. , 1998, Journal of immunology.

[7]  J. Goverman,et al.  In Situ Tolerance within the Central Nervous System as a Mechanism for Preventing Autoimmunity , 2000, The Journal of experimental medicine.

[8]  U. Dirnagl,et al.  Immune surveillance of mouse brain perivascular spaces by blood‐borne macrophages , 2001, The European journal of neuroscience.

[9]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[10]  U. Dirnagl,et al.  Turnover of Rat Brain Perivascular Cells , 2001, Experimental Neurology.

[11]  W. Hickey.  Basic principles of immunological surveillance of the normal central nervous system , 2001, Glia.

[12]  Anat Achiron,et al.  Sandlike appearance of Virchow-Robin spaces in early multiple sclerosis: a novel neuroradiologic marker. , 2002, AJNR. American journal of neuroradiology.

[13]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[14]  Adrian Danek,et al.  Quantification of brain lesions using interactive automated software , 2002, Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc.

[15]  G. Johnson,et al.  Imaging inflammation: Direct visualization of perivascular cuffing in EAE by magnetic resonance microscopy , 2002, Journal of magnetic resonance imaging : JMRI.

[16]  David H. Miller,et al.  Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. , 2002, Brain : a journal of neurology.

[17]  M. El-Sabaawi.  Breakdown of Will , 2002 .

[18]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[19]  R. Ransohoff,et al.  Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.

[20]  Karen J. Ferguson,et al.  Enlarged perivascular spaces are associated with cognitive function in healthy elderly men , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[21]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[22]  F Barkhof,et al.  Enlarged Virchow-Robin spaces: do they matter? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  F. Barkhof,et al.  Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis , 2005, Neurobiology of Disease.

[24]  L. Bö,et al.  Basement Membrane Proteins in Multiple Sclerosis-Associated Inflammatory Cuffs: Potential Role in Influx and Transport of Leukocytes , 2005, Journal of neuropathology and experimental neurology.

[25]  S. Miller,et al.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.

[26]  R. Grossman,et al.  Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. , 2005, AJNR. American journal of neuroradiology.

[27]  B. Engelhardt,et al.  The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. , 2005, Trends in immunology.

[28]  B. Becher,et al.  Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.

[29]  H. Chabriat,et al.  Dilation of Virchow‐Robin spaces in CADASIL , 2006, European journal of neurology.

[30]  A. Traboulsee,et al.  The role of MRI in the diagnosis of multiple sclerosis. , 2006, Advances in neurology.

[31]  B. Becher,et al.  Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain , 2006, Journal of Molecular Medicine.

[32]  Frauke Zipp,et al.  The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases , 2006, Trends in Neurosciences.

[33]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[34]  Marco Rovaris,et al.  Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX , 2007, Journal of magnetic resonance imaging : JMRI.

[35]  C. Mervis,et al.  Rearrangements of the Williams–Beuren syndrome locus: molecular basis and implications for speech and language development , 2007, Expert Reviews in Molecular Medicine.

[36]  R. Klein,et al.  Molecular targets for disrupting leukocyte trafficking during multiple sclerosis , 2007, Expert Reviews in Molecular Medicine.

[37]  J. Wuerfel,et al.  CNS‐irrelevant T‐cells enter the brain, cause blood–brain barrier disruption but no glial pathology , 2007, The European journal of neuroscience.

[38]  J. Rolland,et al.  The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy , 2007, Expert Reviews in Molecular Medicine.

[39]  V. Perry,et al.  What is the blood-brain barrier (not)? , 2007, Trends in immunology.

[40]  R. Ransohoff,et al.  Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale , 2007, Brain pathology.

[41]  F. Paul,et al.  Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis , 2008, PloS one.